Kodiak Sciences Statistics
Total Valuation
Kodiak Sciences has a market cap or net worth of $153.14 million. The enterprise value is $52.26 million.
Important Dates
The last earnings date was Thursday, March 27, 2025, after market close.
| Earnings Date | Mar 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Kodiak Sciences has 52.63 million shares outstanding. The number of shares has increased by 0.32% in one year.
| Current Share Class | 52.50M |
| Shares Outstanding | 52.63M |
| Shares Change (YoY) | +0.32% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 5.54% |
| Owned by Institutions (%) | 47.46% |
| Float | 32.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.07 |
| P/TBV Ratio | 1.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.72, with a Debt / Equity ratio of 0.47.
| Current Ratio | 6.72 |
| Quick Ratio | 6.57 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -84.70% and return on invested capital (ROIC) is -41.12%.
| Return on Equity (ROE) | -84.70% |
| Return on Assets (ROA) | -28.66% |
| Return on Invested Capital (ROIC) | -41.12% |
| Return on Capital Employed (ROCE) | -60.27% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.59M |
| Employee Count | 111 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -60.94% in the last 52 weeks. The beta is 2.26, so Kodiak Sciences's price volatility has been higher than the market average.
| Beta (5Y) | 2.26 |
| 52-Week Price Change | -60.94% |
| 50-Day Moving Average | 4.90 |
| 200-Day Moving Average | 4.48 |
| Relative Strength Index (RSI) | 30.88 |
| Average Volume (20 Days) | 339,270 |
Short Selling Information
The latest short interest is 2.05 million, so 3.89% of the outstanding shares have been sold short.
| Short Interest | 2.05M |
| Short Previous Month | 2.04M |
| Short % of Shares Out | 3.89% |
| Short % of Float | 6.36% |
| Short Ratio (days to cover) | 8.45 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -186.85M |
| Pretax Income | -232.75M |
| Net Income | -176.21M |
| EBITDA | -168.14M |
| EBIT | -186.85M |
| Earnings Per Share (EPS) | -$3.35 |
Full Income StatementBalance Sheet
The company has $168.07 million in cash and $70.35 million in debt, giving a net cash position of $97.73 million or $1.86 per share.
| Cash & Cash Equivalents | 168.07M |
| Total Debt | 70.35M |
| Net Cash | 97.73M |
| Net Cash Per Share | $1.86 |
| Equity (Book Value) | 150.29M |
| Book Value Per Share | 2.85 |
| Working Capital | 146.36M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$117.32 million and capital expenditures -$400,000, giving a free cash flow of -$117.72 million.
| Operating Cash Flow | -117.32M |
| Capital Expenditures | -400,000 |
| Free Cash Flow | -117.72M |
| FCF Per Share | -$2.24 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |